Valeant Pharmaceuticals, Inc.

 Company Summary:
  • A multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics..
Transaction Overview: Significance of the Transaction:
  • Given disruption associated with the recall of NeutraSal, Valeant negotiated a resolution to the escrow associated with its acquisition of Invado, thereby permitting the normalization of business operations.
Healthios Role:
  • Healthios served as financial adviser to Valeant, providing an opinion as to the Fairness, from a financial point-of-view, of the Invado acquisition, inclusive of the escrow resolution
  • This transaction demonstrates Healthios extensive analytical capabilities and our commitment to providing emerging growth companies with sophisticated, objective, experienced advice – irrespective of the size of transaction.